ketamine and semaglutide Weight Loss Houston, TX KureIV Therapy The Promise of Semaglutide: Beyond

Fasting insulin levels, HOMA-IR (a measure of insulin resistance), high-sensitivity C-reactive protein (an inflammation marker), liver enzymes (indicators of fatty liver disease), and advanced lipid panels all provide evidence of metabolic dysfunction that weight alone cannot capture

Not because theyve changed

The opportunity The data points to a major expansion opportunity for oral GLP-1s in the UK market, particularly among younger adults and treatment-hesitant patients

Chronic inflammation is linked to insulin resistance and obesity

Note that the cases used are hypothetical and created solely to illustrate core concepts